Follow the 스피어 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 스피어 has logged 72 public disclosures. Market capitalisation: €945.1bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 한종현. The full history is accessible without an account.
70
Insider Decl.
n/a
Thresholds
n/a
29 ops.
Buy Volume
€639,870
17 ops.
Sell Volume
33Σ signal
Buys n/a€639,870 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,042 of 29,062 companies
41.8
score / 100
Value
32
Quality
51
FCF yld-1.6%
Earn yld0.0%
EV/EBITDA·
ROE55%
Gross mgn18%
Net mgn0.2%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
스피어 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.